amylin analogue
Pramlintide
Answer
Pramlintide is authorised or registered in the US: 1 of the 10 registers read. Highest trial phase: Phase 3 (1 phase 3 trial, 0 with posted results). It has 65 registered trials, 5 of them running. Brand names on the FDA label register: Symlinpen.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
65 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 14 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 41 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Not on the register | MHRA, uk-mhra | 2026-09-03 |
| Canada | Not on the register | Health Canada, ca-dpd | 2026-09-03 |
| Australia | Status unknown | TGA, au-artg | not read |
| Switzerland | Not on the register | Swissmedic, ch-swissmedic | 2026-09-03 |
| Brazil | Not on the register | ANVISA, br-anvisa | 2026-09-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Not on the register | HSA, sg-hsa | 2026-09-03 |
| Turkey | Not on the register | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
Side effects
Trial registerCHANGE ALERTS
Get an email when this changes
One email when the status of Pramlintide changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 65 trials
| NCT07679516 | Postprandial Regulation of Bone Perfusion in Healthy Individuals not yet recruiting participants · register updated 2026-07-09 |
|---|---|
| NCT06422325 | Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide completed · register updated 2026-06-09 |
| NCT03560960 | Multi-Center Development of a Novel Diagnostic Test for Alzheimer's Disease running, but no longer enrolling · register updated 2026-05-28 |
| NCT06619015 | Tailoring Obesity Treatment Trial withdrawn before enrolling anyone · register updated 2026-04-17 |
| NCT07506369 | Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans currently recruiting participants · register updated 2026-04-01 |
| NCT07340775 | Hypersensitivity to Amylin in Post-Traumatic Headache not yet recruiting participants · register updated 2026-01-14 |
| NCT07340788 | Amylin-Induced Migraine Attacks Without Aura not yet recruiting participants · register updated 2026-01-14 |
| 2024-510802-10-00 | The impact of pramlintide on top of semaglutide in obese people with prediabetes no status recorded · register updated 2024-12-03 |
| NCT06046417 | A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes last verified some time ago; the register no longer confirms its status · register updated 2024-04-18 |
| NCT04074317 | Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D completed · register updated 2024-03-27 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.